InMed Pharmaceuticals Inc.
INM
$0.88
-$0.01-1.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.00M | 9.37M | 11.12M | 4.72M | 3.46M |
| Total Receivables | 183.00K | 343.50K | 465.10K | 367.80K | 262.60K |
| Inventory | 947.90K | 890.80K | 961.20K | 814.00K | 1.10M |
| Prepaid Expenses | 660.30K | 191.80K | 321.70K | 507.90K | 644.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.79M | 10.80M | 12.87M | 6.41M | 5.47M |
|
|
|||||
| Total Current Assets | 8.79M | 10.80M | 12.87M | 6.41M | 5.47M |
| Net Property, Plant & Equipment | 764.30K | 881.50K | 992.20K | 1.11M | 1.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.54M | 1.58M | 1.62M | 1.66M | 1.70M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Assets | 11.19M | 13.36M | 15.58M | 9.28M | 8.50M |
|
|
|||||
| Total Accounts Payable | 166.80K | 369.10K | 370.10K | 559.80K | 574.60K |
| Total Accrued Expenses | 697.70K | 592.30K | 1.03M | 846.20K | 784.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 408.10K | 424.80K | 435.50K | 429.20K | 419.70K |
| Total Finance Division Other Current Liabilities | 207.40K | 168.80K | 700.00 | 3.70K | 12.30K |
| Total Other Current Liabilities | 207.40K | 168.80K | 700.00 | 3.70K | 12.30K |
| Total Current Liabilities | 1.48M | 1.56M | 1.84M | 1.84M | 1.79M |
|
|
|||||
| Total Current Liabilities | 1.48M | 1.56M | 1.84M | 1.84M | 1.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 123.80K | 215.50K | 305.80K | 419.30K | 529.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.60M | 1.77M | 2.15M | 2.26M | 2.32M |
|
|
|||||
| Common Stock & APIC | 130.45M | 130.43M | 130.54M | 122.34M | 119.38M |
| Retained Earnings | -120.99M | -118.96M | -117.24M | -115.45M | -113.33M |
| Treasury Stock & Other | 128.60K | 128.60K | 128.60K | 128.60K | 128.60K |
| Total Common Equity | 9.59M | 11.59M | 13.43M | 7.02M | 6.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.59M | 11.59M | 13.43M | 7.02M | 6.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.59M | 11.59M | 13.43M | 7.02M | 6.18M |
|
|
|||||